BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22937147)

  • 1. The Mre11 nuclease is critical for the sensitivity of cells to Chk1 inhibition.
    Thompson R; Montano R; Eastman A
    PLoS One; 2012; 7(8):e44021. PubMed ID: 22937147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mre11 nuclease activity and Ctp1 regulate Chk1 activation by Rad3ATR and Tel1ATM checkpoint kinases at double-strand breaks.
    Limbo O; Porter-Goff ME; Rhind N; Russell P
    Mol Cell Biol; 2011 Feb; 31(3):573-83. PubMed ID: 21098122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mre11-Rad50-Nbs1 (MRN) complex has a specific role in the activation of Chk1 in response to stalled replication forks.
    Lee J; Dunphy WG
    Mol Biol Cell; 2013 May; 24(9):1343-53. PubMed ID: 23468519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of Ku and MRN from DNA ends by Mre11 nuclease activity and Ctp1 is required for homologous recombination repair of double-strand breaks.
    Langerak P; Mejia-Ramirez E; Limbo O; Russell P
    PLoS Genet; 2011 Sep; 7(9):e1002271. PubMed ID: 21931565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
    Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
    J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation.
    Yu Z; Vogel G; Coulombe Y; Dubeau D; Spehalski E; Hébert J; Ferguson DO; Masson JY; Richard S
    Cell Res; 2012 Feb; 22(2):305-20. PubMed ID: 21826105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-specific DNA endonuclease Mus81/Eme1 generates DNA damage caused by Chk1 inactivation.
    Forment JV; Blasius M; Guerini I; Jackson SP
    PLoS One; 2011; 6(8):e23517. PubMed ID: 21858151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Mre11-Rad50-Nbs1 complex in double-strand break repair-facts and myths.
    Takeda S; Hoa NN; Sasanuma H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i25-i32. PubMed ID: 27311583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining.
    Rahal EA; Henricksen LA; Li Y; Williams RS; Tainer JA; Dixon K
    Cell Cycle; 2010 Jul; 9(14):2866-77. PubMed ID: 20647759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe.
    Warren NJH; Eastman A
    J Biol Chem; 2019 Feb; 294(6):1763-1778. PubMed ID: 30573684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.
    Ewald B; Sampath D; Plunkett W
    Cancer Res; 2008 Oct; 68(19):7947-55. PubMed ID: 18829552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells.
    Qi W; Xie C; Li C; Caldwell JT; Edwards H; Taub JW; Wang Y; Lin H; Ge Y
    J Hematol Oncol; 2014 Aug; 7():53. PubMed ID: 25084614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex following irradiation and heat-shock.
    Seno JD; Dynlacht JR
    J Cell Physiol; 2004 May; 199(2):157-70. PubMed ID: 15039997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.
    Montano R; Chung I; Garner KM; Parry D; Eastman A
    Mol Cancer Ther; 2012 Feb; 11(2):427-38. PubMed ID: 22203733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks.
    Fraser M; Harding SM; Zhao H; Coackley C; Durocher D; Bristow RG
    Cell Cycle; 2011 Jul; 10(13):2218-32. PubMed ID: 21623170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Checkpoint activation in response to double-strand breaks requires the Mre11/Rad50/Xrs2 complex.
    Grenon M; Gilbert C; Lowndes NF
    Nat Cell Biol; 2001 Sep; 3(9):844-7. PubMed ID: 11533665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant allele of MRE11 found in mismatch repair-deficient tumor cells suppresses the cellular response to DNA replication fork stress in a dominant negative manner.
    Wen Q; Scorah J; Phear G; Rodgers G; Rodgers S; Meuth M
    Mol Biol Cell; 2008 Apr; 19(4):1693-705. PubMed ID: 18256278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation.
    Davies KD; Cable PL; Garrus JE; Sullivan FX; von Carlowitz I; Huerou YL; Wallace E; Woessner RD; Gross S
    Cancer Biol Ther; 2011 Nov; 12(9):788-96. PubMed ID: 21892012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.